Conversely, Krutilina et al. discovered that miR-18a directly targets HIF-1α, and downregulates hypoxic gene expression [12] and in colon cancer miR22 was shown to inhibit hypoxia [42]. This evidence concerns the gene HIF1A and colonic neoplasm.